Welcome to a new report of my Dividend Diary on the TEV Blog. Here, I report the development of a cash flow-oriented investment approach that focuses on generating a passive income through dividends. Against this background, the goal is not to outperform the market but to put food on the table through a regular income via dividends.
With the Dividend Diary, I document how a cash-flow investment approach can be part of well-balanced wealth management. To keep things simple, I have built three pillars:
- Active income.
- Passive income.
- Conversion.
Dividends fall into the last two categories. They are passive because they provide a cash flow without me going to work. Additionally, they are an essential pillar for conversion since they can be reinvested to generate even more income in the future. That is the Theory. Now let’s get down to practice.
My monthly income with dividends in November:
This month, my cash-flow approach generated the following income through dividends:
- AT&T (33.86 EUR)
- Bristol-Myers Squibb (38.29 EUR)
- CVS Health (15.44 EUR)
- General Mills (33.55 EUR)
- General Dynamics (13.44 EUR)
- AbbVie (39.83 EUR)
- Omega Healthcare (21.83 EUR)
- Procter & Gamble (19.56 EUR)
- Realty Income (16.54 EUR)
- Main Street Capital (8.79 EUR)
- Apple (7.64 EUR)
- Williams-Sonoma (8.79 EUR)
- Amundi MSCI E.M. ETF (291.75 EUR)* /Update: (317.68 EUR)**
*Attention: I’m cheating a little here. The ETF only pays the dividend in December (for the first time in years). However, Amundi has already published the amount of the distribution, so I calculated the rest (taxes, etc.) manually. I am booking the dividend in November to make it easier to compare the development of my cash flow approach.
**Update: In the end, it turned out to be a bit more than I had calculated. I can live with that :).
The total monthly income with dividends in November (after taxes) was: € 575.27 / appr. $ 632
Dividend income report check
Okayish Good performance compared to last year (+ 20 percent YoY). Overall, the development looks like this:
Stock purchases in November
I bought shares in three new companies:
- Kontron (72 shares)
- Main Street Capital (54 shares)
- Alexandria Real Estate (16 shares)
I bought more shares of great companies via my already existing automatic investment plans:
- Emerging Markets ETF
- Japan ETF
- Mayr-Melnhof Karton
- Snap-on
- General Dynamics
- Valmet
- CVS Health
- Diageo
Teamviewer(the saving plan was already paused in May)Henkel(paused in November)- Mensch & Maschine
- USU Software
- Stemmer Imaging
- AbbVie
- Automatic Data Processing
- Bristol-Myers Squibb
- Cisco Systems
- Generals Mills
- IBM
- Pfizer
- Qualcomm
- Realty Income
- Extra Space Storage
- Cboe Global Markets
- Williams-Sonoma
Unilever(paused in November)- Siemens
- PepsiCo. (new).
